In this short review, we describe two new liver-specific contrast agents for MRI that are in clinical development. The main differences among the liver-specific contrast agents available at present are also discussed briefly.
Kohkan Shamsi, MD, PhD
Advertisement
Articles by Kohkan Shamsi, MD, PhD
Advertisement
Latest Updated Articles
Eovist Injection and Resovist Injection: Two New Liver-Specific Contrast Agents for MRIPublished: May 31st 2000 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
AI-Powered Scout Platform Could Enhance Oncology Decision-Making With Data- and Expert-Driven Insights
2
FDA Grants Interchangeability Designation to 2 Denosumab Biosimilars
3
BL-B01D1 Shows Preliminary Efficacy, Favorable Safety in Urothelial Cancer
4
Novel SSTR-Targeted Alpha Therapy Shows “Encouraging” Activity in GEP-NETs
5
